About BML Pharma
BML Pharma is a company based in Manhasset (United States) founded in 1996 was acquired by Endo International in July 2002. BML Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
- Headquarter Manhasset, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Endo International
(Jul 29, 2002)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BML Pharma
Detailed funding history for BML Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BML Pharma
BML Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Endo International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines
|
Locked | Locked | Locked |
Investor details for BML Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BML Pharma
Investment portfolio details for BML Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BML Pharma
Detailed financials for BML Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bml Pharma Comparisons
Peer comparison for BML Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BML Pharma
BML Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of BML Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bml Pharma
Complete news archive for BML Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BML Pharma
BML Pharma was founded in 1996.
BML Pharma is headquartered in Manhasset, United States. It is registered at Manhasset, New York, United States.
BML Pharma was founded in 1996 in Manhasset, United States, as a late clinical-stage company in the biotechnology sector. Small molecule therapeutics were developed by the firm for cancer treatment, infectious diseases, and inflammatory conditions. A lead candidate, Immunol, an oral rinse for oral mucositis in cancer patients, reached Phase III trials. The company was acquired by Endo Pharmaceuticals in 2002 for 14 million in upfront cash.
BML Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
BML Pharma has 1 investor. Key investors include Endo International.